Roche/Genentech to seek a new approval for Lucentis

Roche’s Genentech unit has presented promising data which it hopes will result in an approval for a second indication of the sight drug Lucentis

Novo Nordisk's diabetes drug Victoza gets European OK

Novo Nordisk has been boosted by the news this morning that its diabetes drug Victoza has been approved by regulators in Europe